Bioresorbable Polymers Market Size Set to Cross USD 685 million With the CAGR of 10.85% by 2029 | BlueWeave Consulting

The Asia-Pacific region holds the highest share in the global bioresorbable polymers market, due to the presence of large population, expanding healthcare infrastructure, increasing healthcare expenditure, and rising demand for eco-friendly products. The region has a large consumer base for healthcare products, including orthopedic devices and drug delivery systems, which are major applications of bioresorbable polymers. Additionally, the increasing awareness about sustainable development and the use of eco-friendly products in countries like China and India has further propelled the growth of the bioresorbable polymers market in the region. The presence of major players in the region and the rising demand for innovative medical technologies have also contributed to the dominance of the Asia Pacific region in the bioresorbable polymers market.


New Delhi, May 12, 2023 (GLOBE NEWSWIRE) -- Global bioresorbable polymers market is flourishing because of rising awareness about eco-friendly products and sustainable development, a surging demand for bioresorbable polymers in medical applications due to their biocompatibility and biodegradability, and rising popularity of implantable medical devices and drug delivery systems...

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global bioresorbable polymers market size at USD 428.28 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global bioresorbable polymers market size to grow at a significant CAGR of 10.85% reaching a value of USD 685.23 million by 2029. Major growth drivers for global bioresorbable polymers market include an increasing demand for medical devices that can be safely absorbed by the body, as well as growing awareness about the benefits of these materials among healthcare professionals and patients. The use of bioresorbable polymers in medical applications eliminates the need for a second surgery to remove temporary implants as they can biodegrade inside the human body. It reduces the risk to the patient post-surgery, while also not posing any threat to their body. These polymers are produced by polymerizing bio-based raw materials using engineered industrial processes. The growth of the industry is being further supported by an increase in demand for products due to technological advancements, advancements in plastic materials, and the development of more sophisticated decontamination equipment. However, high production costs of bioresorbable polymers as compared to conventional polymers and limited availability of raw materials for bioresorbable polymers are anticipated to hinder the growth of global bioresorbable polymers market during the period in analysis.


Sample Request @ https://www.blueweaveconsulting.com/report/bioresorbable-polymers-market/report-sample

Global Bioresorbable Polymers Market – Overview

Bioresorbable polymers, also known as biodegradable or bioresorbable polymer materials, are compounds that are safely absorbed by the human body, making them highly sought after in the healthcare sector. These polymers undergo hydrolysis and gradually break down over time, resulting in safe absorption by the body without the need for removal. Polylactic acid, polyglycolic acid, and polycaprolactone are some of the most commonly used bioresorbable polymers, with applications in orthopedics, drug delivery, surgical implants, and various other healthcare uses. Manufacturers typically use vegetable oils derived from sources, such as rapeseed, sunflower corn fiber, castor, soybean, food processing waste, potato, corn, stems, paper mill sludge, livestock waste, and leaves to produce bioresorbable polymers like polysaccharides, proteins, polylactic acid, polyglycolic acid, and polycaprolactone. The bio-based content in these polymers varies depending on the type of feedstock used during manufacturing.

Please Visit the Press Release: https://www.blueweaveconsulting.com/press-release/global-bioresorbable-polymers-market-size-set-to-cross-usd-685-million-by-2029

Impact of COVID-19 on Global Bioresorbable Polymers Market

The COVID-19 pandemic had a detrimental impact on the global bioresorbable polymers market. Due to the imposition of lockdowns and restrictions on travel and manufacturing activities, the market experienced disruptions in the supply chain, resulting in a decline in demand for bioresorbable polymers. The pandemic also led to a decrease in elective surgeries and medical procedures, which are the primary applications of bioresorbable Polymers, further affecting the market negatively. However, the demand for bioresorbable polymers witnessed an increase in applications related to the production of personal protective equipment (PPE), such as masks and gowns. The use of bioresorbable polymers in PPE production has recovered post-pandemic as a result of growing demand for sustainable and environmentally friendly materials. Despite the short-term impact of COVID-19 on the bioresorbable polymers market, the increasing focus on sustainable development and growing demand for eco-friendly products in various industries, including healthcare, is expected to drive the growth of the market during the forecast period.

Global Bioresorbable Polymers Market – By Application

Based on application, the global bioresorbable polymers market is bifurcated into Drug Delivery and Orthopedic Devices segments. The orthopedic devices segment holds a higher share in the global bioresorbable polymers market due to the significant demand for these polymers in orthopedic surgeries. Bioresorbable polymers, such as polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL), are commonly used to fabricate temporary implants in orthopedic surgeries, such as bone fixation and cartilage repair. These polymers can degrade over time and get absorbed by the body, eliminating the need for a second surgery to remove the implant. This not only reduces the risk of complications and infections but also eliminates the need for a second surgery, reducing costs for both patients and healthcare providers. Also, bioresorbable polymers offer superior mechanical strength and biocompatibility, making them an ideal choice for orthopedic implants.

Competitive Landscape

Major players operating in global bioresorbable polymers market include Corbion N.V., Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM N.V., Poly-Med Inc., Ashland Global Holdings Inc., Mimetis Biomaterials, Leiber GmbH, GALAXY Polymers, Biomerics LLC, Solvay SA, Merck KGaA, Evolva Holding SA, and PolyNovo Biomaterials Pty Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don’t miss the business opportunity in the Global Bioresorbable Polymers Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Bioresorbable Polymers Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Bioresorbable Polymers Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.



Recent Developments

  • In August 2021 - Evonik Industries AG, a multinational chemical company, acquired JeNaCell, a biotech company based in Germany, in order to increase its range of biomaterials products for the healthcare sector. The acquisition aided the transformation of Evonik's Nutrition & Care division's product portfolio into system solutions and will expand the division's selection of natural products for the medical technology platform.

Scope of the Report

AttributesDetails
Years ConsideredHistorical Data – 2019–2022
Base Year – 2022
Estimated Year – 2023
Forecast Period – 2023–2029
Facts CoveredRevenue in USD Million
Market CoverageNorth America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Product/ Service SegmentationType, Application, Country
Key PlayersCorbion N.V., Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM N.V., Poly-Med Inc., Ashland Global Holdings Inc., Mimetis Biomaterials, Leiber GmbH, GALAXY Polymers, Biomerics LLC, Solvay SA, Merck KGaA, Evolva Holding SA, PolyNovo Biomaterials Pty Ltd

By Type

  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polylactic-co-glycolic Acid (PLGA)
  • Polycaprolactone (PCL)

By Application

  • Drug Delivery
  • Orthopedic Devices

By Region

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East and Africa (MEA)



Please Find Below Some related Topics:

About Us 

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt. Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com
https://www.blueweaveconsulting.com/

https://www.linkedin.com/company/blueweaveconsulting/